MIRA INFORM REPORT

 

 

Report Date :

16.02.2011

 

IDENTIFICATION DETAILS

 

Name :

SUPRIYA LIFESCIENCE LIMITED

 

 

Formerly Known As :

SUPRIYA CHEMICALS LIMITED

 

 

Registered Office :

207/208, Udyog Bhavan, Sonawala Road, Goregaon (East), Mumbai – 400063, Maharashtra,

 

 

Country :

India

 

 

Financials (as on) :

31.03.2010

 

 

Date of Incorporation :

26.03.2008

 

 

Com. Reg. No.:

180452

 

 

CIN No.:

[Company Identification No.]

U51900MH2008PLC180452

 

 

Legal Form :

A Closely Held Public Limited Liability Company.

 

 

Line of Business :

Manufacturer of  APIs and Drug Intermediates

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (45)

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 347624

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having satisfactory track. Trade relations are reported as fair. Business is active. Payments are reported to be usually correct and as per commitments.

 

The company can be considered normal for business dealings at usual trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – April 1, 2010

 

Country Name

Previous Rating

(31.12.2009)

Current Rating

(01.04.2010)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

LOCATIONS

 

Registered Office :

207/208, Udyog Bhavan, Sonawala Road, Goregaon (East), Mumbai – 400063, Maharashtra, India

Tel. No.:

91-22-40332727 / 66942507

Fax No.:

91-44-26860011

E-Mail :

accounts@supriyalifescience.com

sales@supriyalifescience.com

Website :

www.supriyalifescience.com

 

 

Factory :

A-5/2 Lote Parshuram Industrial Area, MIDC, Chiplun, Taluka Khed, District  Ratnagiri – 415722, Maharashtra India

Tel. No.:

91-2356-272299

Fax No.:

91-2356-272178

Email :

factory@supriyalifescience.com

 

 

DIRECTORS

 

AS ON 29.08.2010

Name :

Mr. Satish Waman Wagh

Designation :

Managing Director

Address :

4 Prabhas Plot No.9 H. F. Society Road, Jogeshwari East, Mumbai – 400060, Maharashtra, India

Date of Birth/Age :

29.12.1955

 

 

Name :

Mrs. Asha Waman Wagh

Designation :

Whole time Director

Address :

Mangirish Building, Plot No.9, Ground Floor, Hindu Friends Society Road, Gogeshwari (East), Mumbai – 400060, Maharashtra, India

Date of Birth/Age :

19.05.1932

 

 

Name :

Mrs. Smita S. Wagh

Designation :

Whole time Director

Address :

Prabhas Plot No.9 H. F. Society Road, Jogeshwari East, Mumbai – 400060, Maharashtra, India

Date of Birth/Age :

23.05.1958

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

AS ON 29.08.2010

Names of Shareholders

 

No. of Shares

 

 

 

Mr. Satish Waman Wagh

 

248100

Mrs. Asha Waman Wagh

 

500

Mrs. Smita S. Wagh

 

1100

Mrs. Kavita Desai

 

25

Dr. Shankar Karmarka

 

225

Mr. Deepak Chavan

 

25

Mr. Dilip Tailsania

 

25

Ms. Sonali Satish Wagh

 

100

Ms. Shivani Satish Wagh

 

100

Total

 

250200

 

AS ON 30.09.2010

 

Category

Percentage

Directors or relatives of Directors

99.88

Other top fifty shareholders

0.12

Total

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of  APIs and Drug Intermediates

 

 

GENERAL INFORMATION

 

No. of Employees :

415 (Office – 115 and Factory – 300)

 

 

Bankers :

  • Saraswat Cooperative Bank, SME Vile Parle Branch, Bholanath Co-Op. Hsg. Soc. Sudhash Road, Vile Parle East, Mumbai – 400057, Maharashtra, India
  • HSBC Bank, Malad (West)

 

 

Facilities :

 

Secured Loan

 

Rs. In Millions

31.03.2010

Rs. In Millions

31.03.2009

ICICI Home Finance Office Loan

27.542

28.449

Citibank Term Loan

16.709

18.642

Saraswat Bank Term Loan 1

5.005

8.489

Saraswat Bank Term Loan 2

1.086

1.549

Saraswat Bank Term Loan 3

1.520

4.633

Saraswat Bank Term Loan 4

7.594

9.673

Saraswat Bank Term Loan 5

3.944

5.844

Saraswat Bank Term Loan 6

0.000

1.693

 

63.4

 

Working Capital Loan

 

 

HSBC Local Bill Discounting

3.723

0.000

Saraswat Bank Foreign Bill Discount

33.297

51.674

Saraswat Bank Local Bill Discount

16.167

14.503

Saraswat Bank Packing Credit

84.673

84.933

Car Loan

1.069

1.437

 

 

Total

202.329

231.519

 

 

 

Unsecured Loan

 

Rs. In Millions

31.03.2010

Rs. In Millions

31.03.2009

Asha Wagh

1.926

6.130

Satish Wagh

2.732

58.908

Smita Wagh

0.722

0.768

Siddhartha Logistics Co. Private Limited

2.700

0.000

Total

8.080

65.806

 

 

 

 

 

Banking Relations :

---

 

 

Auditors :

 

Name :

P. K. Mutha and Co

Chartered Accountant

Address :

Alankar, 3rd Floor, 208, Samuel Street, Masjid Bunder (West), Mumbai – 400003, Maharashtra, India

 

 

Associates/Subsidiaries :

Swastik Industries,

Chiplun

(Manufacturer of Pharmaceuticals API)

 

 

CAPITAL STRUCTURE

 

AS ON 31.03.2010

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

5000000

Equity Shares

Rs.10/- each

Rs. 50.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

250,200

Equity Shares

Rs.10/- each

Rs. 2.502 Millions

 

Share Application Money

 

Rs. 31.260 Millions

 

 

 

 

 

Total

 

Rs. 33.762 Millions

 

 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

 

31.03.2010

31.03.2009

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

 

2.502

0.500

2] Share Application Money

 

31.260

0.000

3] Reserves & Surplus

 

53.144

9.019

4] (Accumulated Losses)

 

0.000

0.000

NETWORTH

 

86.906

9.519

LOAN FUNDS

 

 

 

1] Secured Loans

 

202.329

231.519

2] Unsecured Loans

 

8.080

66.807

TOTAL BORROWING

 

210.409

298.326

DEFERRED TAX LIABILITIES

 

11.044

5.797

 

 

 

 

TOTAL

 

308.359

313.642

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

 

200.072

182.507

Capital work-in-progress

 

9.756

11.924

 

 

 

 

INVESTMENT

 

0.025

0.025

DEFERREX TAX ASSETS

 

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

 

94.794

73.411

 

Sundry Debtors

 

78.421

98.273

 

Cash & Bank Balances

 

10.999

9.339

 

Other Current Assets

 

1.872

1.165

 

Loans & Advances

 

59.719

65.628

Total Current Assets

 

245.805

247.816

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditors

 

129.920

108.748

 

Other Current Liabilities

 

10.032

5.616

 

Provisions

 

7.655

14.676

Total Current Liabilities

 

147.607

129.040

Net Current Assets

 

98.198

118.776

 

 

 

 

MISCELLANEOUS EXPENSES

 

0.308

0.410

 

 

 

 

TOTAL

 

308.359

313.642

 

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

31.03.2010

31.03.2009

 

SALES

 

 

 

 

 

Income

 

469.631

447.273

 

 

Other Income

 

7.256

15.697

 

 

TOTAL                                     (A)

 

476.887

462.970

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Raw Material Consumed

 

308.017

308.473

 

 

Personnel Expenses

 

22.357

18.095

 

 

Manufacturing Expenses

 

583965

41.598

 

 

Administrative & Selling Expenses

 

38.506

34.889

 

 

Increase/(Decrease) in stock

 

(12.669)

3.697

 

 

TOTAL                                     (B)

 

415.176

406.752

 

 

 

 

 

Less

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)      (C)

 

61.711

56.218

 

 

 

 

 

Less

FINANCIAL EXPENSES                         (D)

 

30.653

32.400

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                       (E)

 

31.058

23.818

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

 

8.303

6.498

 

 

 

 

 

 

PROFIT BEFORE TAX (E-F)                               (G)

 

22.755

17.320

 

 

 

 

 

Less

TAX                                                                  (I)

 

10.658

8.196

 

 

 

 

 

 

PROFIT AFTER TAX (G-I)                                  (J)

 

12.097

9.124

 

 

 

 

 

 

Earnings Per Share (Rs.)

 

48

180

 

 

KEY RATIOS

 

PARTICULARS

 

 

 

31.03.2010

31.03.2009

PAT / Total Income

(%)

 

2.53

1.97

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

 

4.84

3.87

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

 

5.10

4.02

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

 

0.26

1.81

 

 

 

 

 

Debt Equity Ratio

(Total Liability/Networth)

 

 

4.11

44.89

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

 

1.66

1.92

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Note – The registered office address of the company has been shifted from 4, Prabhas Plot No. 9, H.F. Society Road, Jogeshwari-East, Mumbai – 400060, Maharashtra, India, to present address w.e.f. 16.12.2009

 

Form 8

Corporate identity number of the company

U51900MH2008PLC180452

Name of the company

SUPRIYA LIFESCIENCE LIMITED

Address of the registered office or of the principal place of  business in India of the company

207/208, Udyog Bhavan, Sonawala Road, Goregaon (East), Mumbai – 400063, Maharashtra, India

This form is for

Creation of charge

Type of charge

Movable property

Particular of charge holder

Name :

Saraswat Cooperative Bank,

Address :

SME Vile Parle Branch, Bholanath Co-Op. Hsg. Soc. Sudhash Road, Vile Parle East, Mumbai – 400057, Maharashtra, India

Email :

njbhatia@rediffmail.com

Nature of instrument creating charge

Agreement of Hypothecation of Movable Property

Date of instrument Creating the charge

04.12.2010

Amount secured by the charge

Rs. 2.608 Millions

Brief of the principal terms an conditions and extent and operation of the charge

Rate of Interest

14.5% p.a. or at such rate as may be determined by the bank from time to time

 

Terms of Repayment

On  demand or by 1.8.2011 if the same is not demanded earlier

 

Margin

30% in bank's favour

 

Extent and Operation of the charge

This is term loan facility

 

Others

Nil

Particulars of the property charged

Hypothecation of plant and machinery, tangible movable property (both present and future) belonging to the borrower and lying and being at the borrowers place of business at

 

Plot no A/5/2, Lote Parshuram INdl Area, MIDC, Tal Khed Dist Ratnagiri  or whereverelse the same maybe.

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                              None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

 

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.45.45

UK Pound

1

Rs.72.90

Euro

1

Rs.61.43

 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

5

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

5

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

5

--PROFITABILIRY

1~10

5

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

5

--RESERVES

1~10

5

--CREDIT LINES

1~10

5

--MARGINS

-5~5

-

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

45

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

-

NB

                                       New Business

-

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.